H.R. 661 · 119th Congress (2025–2027)
MIRACLE Medical Technology Act of 2025
This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.
Show official title
To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 661’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Vern Buchanan (R-FL-16)
- Cosponsors
3 cosponsors
2 original · 1 later
- Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Jan 23, 2025
- Rep. Darren Soto (D-FL-9)· Original · Jan 23, 2025
- Rep. Thomas R. Suozzi (D-NY-3)· Later · Dec 23, 2025
- Policy area
- Health
- Subjects
- Advanced technology and technological innovations
- Advisory bodies
- Data collection, sharing, protection
- Diplomacy, foreign officials, Americans abroad
- Employment and training programs
- Health promotion and preventive care
- Health technology, devices, supplies
- Intellectual property
6 more
- Israel
- Manufacturing
- Medical research
- Prescription drugs
- Public-private cooperation
- Supply chain
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
MIRACLE Medical Technology Act of 2025
Display title, Short title · Introduced in House
Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025
Short title · Introduced in House
To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.
Official title · Introduced in House